GHPGMP

Global Health Policy and Genomics Monitoring Program (GHPGMP) is an international consortium that integrates advances in genomics and pharmacogenomics into public health policy. It coordinates surveillance, research, and guidance to improve decision-making in member countries and regions.

Origin and scope: The program emerged from collaborations among government health agencies, universities, and research institutes in the early 2010s. Pilots have focused on infectious disease genomics, pharmacogenomics-informed prescribing, and health-system readiness, implemented through a network of regional hubs and a central secretariat.

Structure and governance: GHPGMP is governed by a General Assembly of member states, a Scientific Advisory Council, and an Ethics and Data Governance Board, supported by regional coordinating offices. An independent Secretariat manages operations, policy analysis, and partnerships. Funding comes from member dues, philanthropic foundations, and international agencies.

Activities and outputs: It develops data standards for sharing genomic and pharmacogenomic information, maintains a secure data platform, and publishes policy briefs and guidance. It also runs capacity-building programs and pilot projects to integrate pharmacogenomics into national formularies and links pathogen surveillance with public-health decision-making.

Impact and reception: GHPGMP has influenced national policies on precision public health and outbreak response in several regions. Critics cite privacy and sovereignty concerns, potential disparities in capacity, and overlap with existing bodies. Proponents argue that coordinated governance improves equity and efficiency, with ongoing efforts to strengthen inclusive governance.

See also: precision public health, pharmacogenomics, genomic data governance, global health governance.